ID   HS-RMS-1
AC   CVCL_A791
DR   Wikidata; Q54896289
RX   PubMed=10853028;
RX   PubMed=23882450;
CC   Population: Japanese.
CC   Doubling time: ~60 hours (PubMed=10853028).
CC   Derived from site: In situ; Left gluteal muscle; UBERON=UBERON_0002000.
DI   NCIt; C4258; Pleomorphic rhabdomyosarcoma
DI   ORDO; Orphanet_293199; Pleomorphic rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183; PMCID=PMC3713458;
RA   Hinson, Ashley R.P.
RA   Jones, Rosanne
RA   Crose, Lisa E.S.
RA   Belyea, Brian C.
RA   Barr, Frederic G.
RA   Linardic, Corinne Mary
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//
RX   PubMed=10853028; DOI=10.3892/ijo.17.1.119;
RA   Sonobe, Hiroshi
RA   Takeuchi, Tamotsu
RA   Taguchi, Takahiro
RA   Shimizu, Kiichi
RA   Furihata, Mutsuo
RA   Ohtsuki, Yuji
RT   "A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1,
RT   exhibiting MyoD1 and myogenin.";
RL   Int. J. Oncol. 17:119-125(2000).
//